Mondaq All Regions: Food, Drugs, Healthcare, Life Sciences
Holding Redlich
This newsletter includes summaries and links to recent media releases relating to healthcare and medical treatment.
Bereskin & Parr LLP
One of the hot topics in 2017 was the legalization of cannabis for recreational adult use in Canada. Navigating through the weeds to understand the regulation of wacky tabacky can be challenging ...
Burnet, Duckworth & Palmer LLP
On February 16, 2018 the Alberta government released amendments to the regulations under the Gaming, Liquor and Cannabis Act, providing the framework for cannabis retail operation, including licensing.
Miller Thomson LLP
Pursuant to the Local Health Services Integration Act ("LHSIA"), hospitals receive operational funding through Hospital Service Accountability Agreements ("H-SAA").
Osler, Hoskin & Harcourt LLP
The Senate has set June 7, 2018, as the deadline to hold its final vote on the legalization of recreational use cannabis in Canada.
Singh & Associates
On January 12, 2018, the European Medicines Agency's Pharmacovigilance Risk Assessment Committee recommended the suspension of the marketing authorizations for hydroxyethyl-starch solutions for infusion across the European Union.
Singh & Associates
On January 23, 2018, the European Medicines Agency (EMA) has published its annual report titled ‘Human medicines: Highlights of 201741.
Gowling WLG
There is now more legal certainty for ten insect species, the distribution of which is already permitted in some EU countries.
Singh & Associates
On January 03, 2018, Novartis announced that KisqaliR (Ribociclib) has received FDA Breakthrough Therapy designation for initial endocrine-based treatment, in combination with tamoxifen or an aromatase inhibitor,...
Gorodissky & Partners
January 2018 was the first time in a Russian jurisdiction a specific law on telemedicine technologies took effect—namely the Federal Law on amending certain legislative acts of the Russian Federation on issues...
Iberian Lawyer
The emergence of cutting-edge healthcare technology is rendering current legal frameworks obsolete, while the sector is also generating significant levels of transactional work
Gun + Partners
The Amendment mostly clarifies the inconsistencies and removes the burdensome obligations created with the Regulation as expected.
Singh & Associates
On January 16, 2018, the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) issued update to pharmaceutical companies on its exit preparations from the European Union (EU).
Singh & Associates
On January 11, 2018, the US-FDA announced that it is requiring safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than 18 years of age ...
Singh & Associates
The United States Food and Drug Administration (USFDA) on January 18, 2018, released a draft guidance "Public Warning and Notification of Recalls Under 21 CFR Part 7, Subpart C" explaining new policy steps for ...
Seyfarth Shaw LLP
Changes to both federal and Texas law which occurred in 2017 will broaden the circumstances under which physicians can make use of telemedicine services.
Dickinson Wright PLLC
Our nation is beset by an opioid epidemic that is colossal in scope and devastating in effect. The human and economic toll of this plague is stunning. Every day, more than 100 Americans die from an opioid overdose.
Sheppard Mullin Richter & Hampton
On January 25, 2018, Associate Attorney General Rachel Brand issued a memorandum on behalf of the U.S. Department of Justice (DOJ) (the "Brand Memo") ...
Haug Partners
Antitrust Associate Amanda Hamilton published an article in FDLI's Update Magazine for the January-February 2018 Issue entitled "Navigating an FTC Drug Pricing Investigation
Thompson Coburn LLP
The final rule governing changes to the Substance Abuse and Mental Health Services Administration (SAMHSA) regulations became effective February 2, 2018.
Most Popular Recent Articles
Borden Ladner Gervais LLP
Our annual thought leadership report is now available to download.
Norton Rose Fulbright Australia
Businesses in food and agriculture industries should be particularly alive to the risk of slavery in their supply chains.
Holman Webb
Future action for non-compliance with the ACL in the marketing of therapeutic goods may result in much higher penalties.
Carroll & O'Dea
The appeal addressed how the trial judge could properly choose between competing expert opinions on mental harm.
Holman Webb
A genomic profile may help a doctor make personalised health decisions, but also raises a number of ethical challenges.
Norton Rose Fulbright Australia
The article considers the responses to some of the key recommendations and potential implications of these responses.
Holman Webb
The Appeal decision confirms the need to understand medical malpractice and civil liability policy terms and conditions.
Carroll & O'Dea
This article focuses on some information provision issues addressed in the new ethical guidelines on the use of ART.
Morgan Lewis
Amgen paints a different picture as to the bad actor during the parties' negotiations pursuant to the Biologics Price Competition and Innovation Act.
Carroll & O'Dea
The balancing exercise between confidentiality and the patient's potential risk to the community has become no easier.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter